15 in the run for NA-4 by-election

Published
0

PESHAWAR: Fifteen candidates are in the run for the by-election on the National Assembly constituency of NA-4, Peshawar IV, as the returning officer released final list of contestants and allotted them election symbols on Wednesday.

The seat had fallen vacant with the death of a disgruntled MNA of Pakistan Tehreek-i-Insaf, Gulzar Khan. Polling will be held on Oct 26.

The contesting candidates are: Arbab Amir Ayub of PTI, Asad Gulzar Khan of PPP, Khushdil Khan of ANP, Nasir Khan Musazai of PML-N, Wasil Farooq Jan of JI, Mohammad Shafiq Ameeni of Tehreek-i-Labaik Pakistan and independent candidates Amanullah Khan Afridi, Liaqat Ali Khan, Dr Mubashir Khan, Samiullah, Shaukat Khan Mohmand, Ziaur Rehman, Farhan Qaiser, Mohammad Tanveer and Maulana Waheed Alam.

The ECP has already issued a code of conduct for the polls, placing ban on development schemes by the federal, provincial and local governments in the area.

Published in Dawn, October 5th, 2017

Opinion

Editorial

Nuclear uncertainty
Updated 23 Oct, 2026

Nuclear uncertainty

With matters frozen in the political and diplomatic spheres, it will take military-to-military engagement to prevent miscalculation in the strategic sphere.
Auto illusion
Updated 23 Oct, 2026

Auto illusion

PAKISTAN’S draft auto policy 2026-31 is ambitious in its targets and directionless in its strategy. It promises...
Two crimes
23 Oct, 2026

Two crimes

THE senseless killing of a teenager by his employers in Multan is a crime that deserves unqualified condemnation. It...
Makkah pact clarity
Updated 22 Oct, 2026

Makkah pact clarity

Fresh aggression can kick off a firestorm that will be in no one’s control, hence it is best to abandon such reckless plans.
Common ground
Updated 22 Oct, 2026

Common ground

Regrettably, the two sides still fail to see the country’s economic, security, and governance crises as challenges that must be solved politically.
The treatment gap
22 Oct, 2026

The treatment gap

A BREAST cancer diagnosis no longer carries the bleak outlook it did a generation ago. Targeted medicines,...